Condition

DCIS

ClinicalTrials.gov condition label

Clinical trials34

Recruiting8

Common interventions25

Lead sponsors shown15

Clinical trials

34 shown

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)NCT07292246 · 2025-09-09

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)NCT06902311 · 2025-02-19

Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCISNCT05912569 · 2023-06-13

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast CancerNCT03936478 · 2022-05-16

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in SituNCT04722692 · 2020-03-01

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerNCT04084730 · 2019-08-30

Perioperative Mindfulness ProposalNCT04049214 · 2019-07-31

The PREDICT Registry:NCT03448926 · 2018-02-27

Pilot Trial of Preop Partial Radiation in Breast Cancer PatientsNCT07178665 · 2025-09-02

Robotic Nipple Sparing Mastectomy with Immediate ReconstructionNCT06860217 · 2025-04-01

NOT_YET_RECRUITING

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCISNCT06217458 · 2025-03-01

NOT_YET_RECRUITING

THRIVE Study: Positive Affect Training for Endocrine Therapy Medication AdherenceNCT06388304 · 2024-03-12

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast CancerNCT05900986 · 2023-07-14

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)NCT04797299 · 2022-11-23

ACTIVE_NOT_RECRUITING

Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast CancerNCT05436808 · 2022-07-15

The AUS-PREDICT Registry for DCIS Patients With DCISionRT TestingNCT04916808 · 2021-07-02

ACTIVE_NOT_RECRUITING

Molecular Analysis of the Sloane ProjectNCT05868252 · 2020-03-01

Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIsNCT04170920 · 2020-02-17

Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer PatientsNCT03931928 · 2019-09-10

Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma BreastNCT03878342 · 2019-05-10

ACTIVE_NOT_RECRUITING

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy ToxicityNCT04245150 · 2019-03-21

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for SurgeryNCT03535506 · 2018-10-08

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCISNCT02926911 · 2017-02-22

ACTIVE_NOT_RECRUITING

Management of Low-risk (Grade I and II) DCISNCT02492607 · 2017-02-13

ACTIVE_NOT_RECRUITING

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCISNCT02766881 · 2016-08-01

Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast IrradiationNCT02637024 · 2016-05-01

CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)NCT02365714 · 2015-02-01

Tumor: Breast Ratio StudyNCT02216136 · 2014-04-14

Impact of Radiation Therapy on Breast Conservation in DCISNCT02248662 · 2013-08-01

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)NCT01023477 · 2009-12-01

DC Vaccine for Patients With Ductal Carcinoma In SituNCT02061332 · 2009-07-01

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal WomenNCT00256217 · 2004-09-21

MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-SituNCT00586326 · 2003-08-01

Educational Interventions for Patients With DCISNCT00148655 · 2003-05-01

Common interventions

radiotherapyRADIATION2 (Z)-Endoxifen supplementation according to genotypeDRUG1 (Z)-Endoxifen supplementation according to plasma levelsDRUG1 7-gene biosignatureDEVICE1 Accelerated Partial Breast IrradiationRADIATION1 Active MonitoringOTHER1 AnastrozoleDRUG1 APBI: 27.5 GyRADIATION1 APBI: 30 GyRADIATION1 Breast BiopsyPROCEDURE1 Breast RadiotherapyRADIATION1 Chloroquine Low Dose (250mg/week)DRUG1 Chloroquine Standard Dose (500mg/week)DRUG1 CK Stereotactic Accelerated Partial Breast IrradiationRADIATION1 Contrast Enhanced MammographyDIAGNOSTIC_TEST1 DCISionRT TestDIAGNOSTIC_TEST1 Decision BoardDEVICE1 Delay sentinel node biopsyPROCEDURE1 Delayed SLNDDIAGNOSTIC_TEST1 digital mammographyDEVICE1 Endoscopic nipple sparing mastectomyPROCEDURE1 HandX endoscopic instrumentDEVICE1 HER-2 Pulsed Dendritic cell VaccineBIOLOGICAL1 Late SLNDDIAGNOSTIC_TEST1 LifeExtend-AIDEVICE1

Leading sponsors

Ontario Clinical Oncology Group (OCOG)3 Dana-Farber Cancer Institute2 Georgetown University2 PreludeDx2 Abramson Cancer Center at Penn Medicine1 Alliance Foundation Trials, LLC.1 Case Comprehensive Cancer Center1 Clinical Hospital Center Rijeka1 European Institute of Oncology1 Hoag Memorial Hospital Presbyterian1 Hologic, Inc.1 Indiana University1 Inova Health Care Services1 Integro Theranostics1 Joanna Arch1

Trial status mix

COMPLETED14

RECRUITING8

ACTIVE_NOT_RECRUITING5

NOT_YET_RECRUITING2

TERMINATED2

SUSPENDED1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE212

NA11

PHASE15

EARLY_PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.